DoctorLaura Laslett
Senior Research Fellow - Epidemiology
Menzies Institute for Medical Research
Orcid identifier0000-0002-4336-0095 (opens in a new tab)
- Senior Research Fellow - EpidemiologyMenzies Institute for Medical Research
- +61 3 6226 7704 (Fax)
- +61 3 6226 7736 (Work)
- Menzies Institute for Medical Research, Menzies Institute for Medical Research, 356-02 Medical Science 2, Hobart CBD Campuses, TAS
SERVICE & ENGAGEMENT
1-19 out of 19
- EVENTS AND COMMUNITY ENGAGEMENT29 May 2026 - 29 May 2026Biannual Community Event
- MEDIA INTERVIEW13 Mar 2026 - 13 Mar 2026Dr Laura Laslett, a sleep expert and epidemiologist, discusses the significant impact of poor sleep on daily functioning
- EVENTS AND COMMUNITY ENGAGEMENTConsumer Advisory Committee Meeting11 Feb 2026 - 11 Feb 2026Quarterly governance meeting Members terms expiring and extensions Discussion on Flagship strategy day 18 February Discussion on Flagship CCI training workshop 26 March Research presentation - Professor Bruce Taylor Research plan - Dr Laura Laslett Discussion on academic pathway progression TASTest overview
- EVENTS AND COMMUNITY ENGAGEMENT2025.08.13 - Consumer and Community Reference Committee (C&CRC)13 Aug 2025 - 13 Aug 2025Governance Meeting Members terms; re-elect Chair and Deputy Chair for a further 2-year terms each. Discuss MS Symposium 11 August and feedback Presentation by Dr Yuan Zhou on EBV and Multi-omics research. Presentation by Dr Laura Laslett on her feasibility study about MS and Sleep. Discuss training and development needs for C&CRC members
- EVENTS AND COMMUNITY ENGAGEMENT2025 Multiple Sclerosis Symposium11 Aug 2025 - 11 Aug 2025This was a one-day symposium supported by funding from the NHMRC Centre of Research Excellence (CRE) funding, which focused on sharing the latest research and technological advances, as well as forming collaborative connections across different areas of medical research. An estimated total of 70 people attended in person and 20 people attended online, including research team members, collaborators, and MS consumer partners. Overall theme: Understanding the genetic and molecular basis of multiple sclerosis (MS). Co-chairs: Dr Xin Lin, Dr Roisin Moloney. Keynote speakers: Associate Professor Justin Rubio, Professor Jana Vukovic. Panel discussion topic: From Bench to Bedside - Translating Scientific Discovery into Real-World Impact for People Living with MS. Panel discussion speakers: Anna Ritchie (MS consumer partner), Lynda Hanlon (MS consumer partner), Associate Professor Justin Rubio (geneticist), Professor Jana Vukovic (neuroimmunologist), Professor Bruce Taylor (MS neurologist). MS research showcase presenters: Chaw Hsu Thwe (PhD student), Panteha Khaledi (PhD student), Dr Nicholas Blackburn (senior research fellow), Himanshu Saraswat (PhD student), Eleanor Sabey (PhD student), Liyang Xu (PhD student), Md Mobarok Hossain (PhD student), Dr Shwathy Ramesan (postdoctoral fellow), Dr Jake Cashion (junior research fellow), Surbhi Agarwal (PhD student), Jia Yi Hoe (PhD student), Dr Laura Laslett (senior research fellow), Mohammed Obsa (PhD student), Dr Julie Campbell (senior research fellow). MS-CRE innovation award presenters: Dr Tyra Fraser, Dr Xin Lin Scientific advisory committee: Andrew Potter, Sharlene Brown, Professor David Mackey, Professor Dominique Cadilhac, Professor Erica Fletcher, Professor Pamela McCombe, Professor Stuart MacGregor, Professor Trevor Kilpatrick, Professor Michelle McIntosh.
- MEDIA INTERVIEW10 Aug 2025Radio interview
- MEDIA INTERVIEW10 Aug 2025 - 10 Aug 2025Dr Laura Laslett discusses her MS Sleep Study. "The Hobart region has one of highest frequencies of Multiple Sclerosis in Australia, and more people are being diagnosed with it than ever before. Now, a Tasmania-based research project will investigate how wearable technology might help, with Dr Laura Lasslett from the Menzies Institute for Medical Research." Laura discussed her research that is being funded by an incubator grant from MS Australia: Can wearable tech and apps help track MS symptoms more effectively? Dr Laura Laslett – Menzies Institute for Medical Research, University of Tasmania, TAS This project investigates whether smartwatches and the MySymptoMS app can effectively monitor sleep and symptoms in people with MS over extended periods. Dr Laura Laslett will assess whether these tools are practical, acceptable, and capable of capturing symptom changes that traditional methods often miss. The findings could inform the design of future clinical trials and support the development of more effective treatments for sleep problems in MS. “Sleep disturbance is a major issue for many people with MS, but we still don’t have good enough ways to measure it,” said Dr Laslett. “This study is about getting the foundations right and making sure we’re using tools that work for the people living with the disease.”
- MEDIA INTERVIEW5 Aug 2025 - 5 Aug 2025Jeremy Henderson and Dr Tennille Luker are joined by MS researchers, Dr Laura Laslett, Dr Monokesh Sen and Dr David Stacey, to discuss their new Incubator Grants, supporting their out-of-the-box ideas aimed at opening new directions in MS research. Can wearable tech and apps help track MS symptoms more effectively? Dr Laura Laslett – Menzies Institute for Medical Research, University of Tasmania, TAS This project investigates whether smartwatches and the MySymptoMS app can effectively monitor sleep and symptoms in people with MS over extended periods. Dr Laura Laslett will assess whether these tools are practical, acceptable, and capable of capturing symptom changes that traditional methods often miss. The findings could inform the design of future clinical trials and support the development of more effective treatments for sleep problems in MS. “Sleep disturbance is a major issue for many people with MS, but we still don’t have good enough ways to measure it,” said Dr Laslett. “This study is about getting the foundations right and making sure we’re using tools that work for the people living with the disease.”
- MEDIA INTERVIEW5 Aug 2025Voiceover: Welcome to The Raw Nerve, the official podcast of MS Australia, a conversation space for all things multiple sclerosis. Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community, those living with MS and their families and carers, together with leading clinicians, researchers, and advocates. Jeremy Henderson: Hello. Welcome to The Raw Nerve. I’m your host, Jeremy Henderson. Today on The Raw Nerve, we’re talking about new and innovative MS research. Research that’s just been funded under MS Australia’s latest Research Incubator Grant round announced late last month. Today, we’ll be speaking with three eminent MS researchers about their new research projects. I’d like to welcome one of those researchers into the studio now, Dr Laura Laslett from Menzies Institute for Medical Research at the University of Tasmania in Hobart. Welcome to you, Laura. Laura Laslett: Thank you. It’s lovely to be here. Jeremy Henderson: I’m also joined today by my colleague who’ll be familiar to our guests and to many of our listeners, Dr Tennille Luker is MS Australia’s newly appointed Head of Research. Welcome Tennille and congratulations! Tennille Luker: Thank you and thank you. It’s great to be here to talk about these. Jeremy Henderson: Okay. Let’s jump right in, Tennille. So first question to you, I wonder if you could tell us about the incubator grant research funding round that’s just been announced. Tennille Luker: Absolutely. So, MS Australia has just announced the recipients of its first incubator grant round for 2025, and it’s a really exciting moment for the MS research community. This round has funded four innovative early stage projects, each designed to explore bold new ideas in MS research. The grants are valued at up to $25,000 over one year, and they’re all about helping researchers generate the kind of preliminary data that can unlock larger funding opportunities down the track. What’s particularly exciting about this round is the diversity of the research being supported. We’ve got projects looking at myelin repair using immune cell dried particles. We’ve got a project looking at genetic risk and immune response to EBV (Epstein-Barr virus), which is a known risk factor for MS. Changes to blood vessels in the brain in MS and the use of wearable tech and symptom tracking apps to better understand sleep and symptom variability in people with MS. These are all high potential ideas that could lead to major breakthroughs, and they reflect the calibre of applications we received this year. So, the incubator grant scheme itself has a strong track record. Historically for every dollar invested, researchers have gone on to secure an additional $27 into follow-on funding, which really accelerates progress. So this round is not only a celebration of new ideas, it’s also a strategic investment in the future of MS research. Jeremy Henderson: Thanks, Tennille, I think you’ve partly answered this next question already, but I’ll ask you anyway. So, MS Australia plays this vital role not only in funding research, but also in coordinating MS research in Australia. I wonder if you can talk about the role MS Australia plays in that stewardship of MS research and why that’s so vital. Tennille Luker: Yep. So, MS Australia plays a central role in MS research in this country, and as I said, it’s not just about funding-though that’s a big part of it-it’s about how we help bring people, ideas and resources together to support and strengthen the incredible work happening across the research community. While we don’t run the research ourselves, we play a crucial role making sure it happens in the right places with the right people and with the right focus. We find researchers across various institutes and go through a rigorous, independent grants process. So there’s all of trust in how these decisions are made. But what makes MS Australia’s role so vital is the coordination. We help connect the dots, whether that’s through our national collaborative research platforms, which involves groups of experts focusing on specific topics in MS. So, things like genetics or MS Australia’s Brain Bank, which gives researchers access to well-characterised, post-mortem brain tissue cells that are incredibly hard to come by, but essential for understanding MS at a cellular level. These kinds of resources are game changers for the research community. In addition to this, MS Australia also communicates this research. We help translate it, share it, and make sure it reaches the right people, which is the MS community, whether that’s through the MS WIRE, social media, or throughout symposiums and conferences. We help make sure the science just doesn’t sit in a journal; it gets out to the world. So that’s what stewardship means to us. It’s about keeping the whole ecosystem moving forward strategically and collaboratively. Jeremy Henderson: Excellent. Thank you, Tennille. Okay, Laura, if we can actually turn to you and start talking about some of this wonderful research. I wonder if you can tell me about your latest research project. Tell me about the project, what are you doing, how are you doing it, and what are you hoping to find? Laura Laslett: So, the project that I proposed and which MS Australia has funded, is looking to collect better data on sleep. So, why I’m interested in this is because sleep is a really big problem in people living with MS. And traditionally, we assess that on a large-scale using questionnaires and there’s many advantages to that, but there’s evidence out there that says that when we just collect data using questionnaires, we’re missing bits of the picture. And so, one of the things that we wanted to do was to look at collecting data using activity monitors and sleep trackers. Now, we’re not the first people to collect data on sleep using activity monitors, which are basically research-grade Fitbits. But one of the things that we wanted to do was to actually really think about, well, we already know from other data out there that activity monitor data is complementary, but we want to know not just is it complementary, but we also want to know other things like… Mostly, data using these devices is collected for one week, but is that enough? There’s other data that suggests that, probably, for people with MS who’ve got lots of complex things going on, we probably need data longer than that. We probably need to be collecting data from symptom trackers as well. And all this is great, but we need to be, before we really just start just doing these things just routinely, we actually need to sit down and think about the data that we’re collecting. Is it actually feasible to do this? Is it acceptable to people? We need to be asking those kind of basic questions before we roll out these kind of things at scale. Is this acceptable to people? Is it feasible? If it’s not acceptable or not feasible, who is it not feasible for? Is there something special about these people that we need to be asking more questions of? And if one week’s not long enough, is two long enough? Maybe we might need three. And that these things need to speak to also feasibility and acceptability, because at some point, people don’t want to wear these things forever. You’ve got to draw the line somewhere, but these things are not just academic questions. Obviously, these things are always nice to know, but this kind of level of knowledge is important because when we’re answering questions that matter. For example, does this treatment improve sleep? The choice of the data that we use to answer that question matters. It might be the difference between working out whether a treatment works or it doesn’t work. And so, to be able to be using the best data; to be asking the right questions, the most important questions to get the full picture that we need, we need to be making sure that we’ve got the basics right and to figure out how do we collect the best data on sleep before we just go out and run it in the world. Jeremy Henderson: Tennille, keen to get your thoughts on this project in terms of that question around feasibility and acceptability. Maybe this was a question for Laura as well, but in terms of people’s awareness around activity trackers and smart watches and sort of that acceptability and the norm of so many people wearing them, I think Tennille might be wearing one now, and I know I’m wearing a garment now as well. And so, I’m wondering whether, just curious to know your thoughts, Tennille, and also Laura, whether that makes this kind of project easier in terms of the norms around existing behaviours with people tracking those kind of things. Tennille Luker: Yeah. I think Laura’s project really highlights the kind of person-centered innovation we are seeing in this round of incubator grants. I think, as Laura highlighted, it’s not just about collecting data, it’s making sure the data is meaningful, usable for people living with MS. And I think by testing the feasibility of using smart watches and the mySymptoms app over long periods of time, Laura seems to be addressing a real gap on how we understand sleep and symptom variability in MS. From a feasibility perspective, I think smart watches is a great way to go and using apps. Traditional surveys and short-term monitoring often miss the nuance of day-to-day changes. And I think this project is asking, as Laura said, can they do it better, and can they capture those fluctuations in a way that actually informs treatment. So, it’s a foundational step, but an important one. And if these tools prove to be practical and acceptable, they could really reshape how we design clinical trials plus link interventions in MS and ultimately lead to better outcomes for people affected by MS. Jeremy Henderson: Thank you, Tennille. Laura, going forward, how would you like to see this type of data used? Laura Laslett: Well, what I want to see this data used for and used as, is to help make decisions about how we’re going to collect data on sleep, when we’re doing studies where we’re figuring out whether stuff works. Because the choice of an outcome measure can make or break a clinical trial. Because we just kind of assume that if something works, we’re going to figure it out. But if you don’t use the right outcome measure, then it can be almost impossible to figure out that something that does actually work works. We need to have the right outcomes to be sending the right signals to regulators and people who are paying for it…for treatments, that these things are worth paying for. But also, for every piece of information that we’re collecting comes at a cost. It’s my life hours, it’s your life hours, the life hours of the people analysing studies. And the better the data you collect, the more likely it is that you’re going to have to inconvenience fewer people to be part of the clinical trials to get the answer you want. That’s really what we’re all after; is that we want to get the answers to the questions that matter to us, in a way that is cheapest and inconveniences the fewest number of people for the shortest period of time to get the answer we want, because we all want answers yesterday to today’s problems, but everything takes time. So, it’s worth thinking about the data that we collect and to how we can do it best. Jeremy Henderson: Can I ask, what inspired you to get into MS research, and what do you most enjoy about this work? Laura Laslett: I got into MS research from another unrelated area of research. So I’m an epidemiologist and I have been working in that in a long time. But one of the reasons I got into MS was the opportunities that are available. One of the things is that there’s such a talent pool in Australia of researchers with plenty of talent, but there’s never enough money. There’s never…there’s not always the right opportunities at the right time. And one of the things about MS research, there’s a lot of opportunity. The MS community loves research. They want research done, and importantly, they are willing to pay for it to be done in their name. They’re serious about figuring out what their priorities are. That’s just really important for someone like me. When a group says, “This is what’s important to us.” And then if something that meets my skill set, I’m able to contribute. It’s just personally meaningful to me to be able to be doing research that’s important to people, and that it’s important, and that the people who want it are willing to fund it. There’s always work, but there’s not always funding and it’s not always the right priorities. So, I’ve been able to find a niche in MS research that’s personally meaningful to me and just gives me a lot of opportunity and it means that I’m able to do something that’s personally meaningful to me, that makes me feel like I’m able to make a difference in my little corner of the research world for people living with MS, to make their lives better. Jeremy Henderson: Tennille, at MS Australia, we can absolutely speak to the MS community’s incredible passion and support and enthusiasm for MS research. Tennille Luker: Well, we conduct a research priority survey, research and advocacy priority survey every few years. We just conducted one this year that we’re in the process of analysing. But definitely when it comes to research, the MS community are absolutely passionate about it. They’re passionate about it from the perspective of advocacy as well, and they’re incredibly engaged as well. So, I’m sure this year’s survey results are going to show very similar results as well. Jeremy Henderson: Laura, just one final question for you. Just in terms of participation in your trial, how do you go about that, and how difficult or easy is it to find people willing to be involved in that research? Laura Laslett: Well, it’s always a bit of a challenge trying to find people to take part in studies because it’s people’s life hours. And so we are recruiting already. So this study is underway. We’ve already had two people finish our study, which is three weeks long. We’ve got a link up, which we could provide. We’re trying to recruit people locally to us in Southern Tasmania because we’d like people to come and pick up their activity monitors because they’re valuable to us, and we are trying to avoid them getting lost, because getting lost with three weeks data, which is three weeks of someone’s life. That’s very sad, and I haven’t had to deal with that yet, but I can see that will be a very sad day when that first happens to me. So we’re trying to recruit locally in Southern Tasmania for people living with MS. So, people living with MS in Southern Tasmania, I’d be super keen to hear from you, and I’ll send along the link. Recruitment’s been a slow start so far, but we have two people who’ve finished, and we’ve already had some interest in the last couple of days. And so, we’re aiming to recruit 50 people living with MS, probably in Southern Tasmania, but we also have had interest in Northern Tasmania as well. And so, we’ll be looking to post out the activity monitors to those people. There’s 33,000 people living with MS in Australia. So, the people living with MS in Australia have always historically been very interested in taking part in research, but we’re trying to recruit locally just for our own, to make it easier for us. But I would love it if we would have a great number of people local to us in southern Tasmania contact us to take part in the next couple of weeks. That would be amazing. Jeremy Henderson: Excellent. Well, we’ll certainly add that link into the show notes of the podcast. So, look, we’ll take a short break now. Can I thank our first guest, MS researcher, DrLaura Laslett. Thank you very much for joining us on The Raw Nerve Podcast. Tennille Luker, don’t you go anywhere. We’ll be right back after the short break with our next guests. Thank you.
- MEDIA PUBLICATION30 Jul 2025Congratulations to Dr Alastair Fortune and Dr Laura Laslett of our MS Research Flagship who've both been awarded MS Australia Incubator Grants. These grants are designed to encourage new ideas while helping grow and strengthen a world-class Australian MS research community 💡🔬🙌 🧠 Alastair's project asks the question "Are brain vascular cells dysfunctional in MS?" and will explore whether pericytes, brain vascular cells that regulate blood flow and communicate with immune cells, play a role in the early stages of MS. "Pericytes are often overlooked in MS research, but they may hold vital clues to how the disease starts and progresses," said Alastair. "Understanding their role could open up new treatment options beyond the immune system." 🛌 Laura will be investigating whether smartwatches and the MySymptoMS app can effectively monitor sleep and symptoms in people with MS over extended periods. “Sleep disturbance is a major issue for many people with MS, but we still don’t have good enough ways to measure it,” said Laura. “This study is about getting the foundations right and making sure we’re using tools that work for the people living with the disease.”
- MEDIA PUBLICATION30 Jul 2025Congratulations to Dr Alastair Fortune and Dr Laura Laslett of our MS Research Flagship who've both been awarded MS Australia Incubator Grants. These grants are designed to encourage new ideas while helping grow and strengthen a world-class Australian MS research community 💡🔬🙌 🧠 Alastair's project asks the question "Are brain vascular cells dysfunctional in MS?" and will explore whether pericytes, brain vascular cells that regulate blood flow and communicate with immune cells, play a role in the early stages of MS. "Pericytes are often overlooked in MS research, but they may hold vital clues to how the disease starts and progresses," said Alastair. "Understanding their role could open up new treatment options beyond the immune system." 🛌 Laura will be investigating whether smartwatches and the MySymptoMS app can effectively monitor sleep and symptoms in people with MS over extended periods. “Sleep disturbance is a major issue for many people with MS, but we still don’t have good enough ways to measure it,” said Laura. “This study is about getting the foundations right and making sure we’re using tools that work for the people living with the disease.”
- MEDIA PUBLICATION30 Jul 2025 - 30 Jul 2025MS Australia media release about its Incubator Grant round featuring MS Research Flagship recipients Dr Laura Laslett and Dr Alastair Fortune. Are brain vascular cells dysfunctional in MS? Dr Alastair Fortune – Menzies Institute for Medical Research, University of Tasmania, TAS This project explores whether pericytes, brain vascular cells that regulate blood flow and communicate with immune cells, play a role in the early stages of MS. Dr Alastair Fortune and his team will compare pericytes from people with and without MS to see if they behave differently, and how this might affect blood vessels, immune activity and disease progression. The findings could reveal new insights into how MS begins and help researchers explore new treatment options. “Pericytes are often overlooked in MS research, but they may hold vital clues to how the disease starts and progresses,” said Dr Fortune. “Understanding their role could open up new treatment options beyond the immune system.” Can wearable tech and apps help track MS symptoms more effectively? Dr Laura Laslett – Menzies Institute for Medical Research, University of Tasmania, TAS This project investigates whether smartwatches and the MySymptoMS app can effectively monitor sleep and symptoms in people with MS over extended periods. Dr Laura Laslett will assess whether these tools are practical, acceptable, and capable of capturing symptom changes that traditional methods often miss. The findings could inform the design of future clinical trials and support the development of more effective treatments for sleep problems in MS. “Sleep disturbance is a major issue for many people with MS, but we still don’t have good enough ways to measure it,” said Dr Laslett. “This study is about getting the foundations right and making sure we’re using tools that work for the people living with the disease.”
- RECOGNITIONMenzies Best of the Best10 Apr 2025
- CONFERENCE ROLEPoster presentation at Australasian Epidemiology Association Conference1 Jan 2025
- RECOGNITIONAustralian Rheumatology Association President's Prize for Collaborative Research21 May 2024
- EVENTS AND COMMUNITY ENGAGEMENT1 Jan 2024Annual Community event
- EVENTS AND COMMUNITY ENGAGEMENT1 Jan 2023Research with Connections 2023 symposium
- EVENTS AND COMMUNITY ENGAGEMENTResearch with Connections, 20211 Jan 2021World MS Day community event